Time‐restricted versus standard‐duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON‐96 trial

Annoek E C Broers, Ellen Meijer, Bronno van der Holt, Cornelis N de Jong, Erfan Nur, Geerte L van Sluis, Goda Choi, Michel van Gelder, Johan A Maertens, Jürgen Kuball, Dries Deeren, Heleen A Visser‐Wisselaar, Lamberdina A H M Meulendijks, Jan J Cornelissen, the HOVON Stem Cell Transplantation Workin · 2024

Read Time‐restricted versus standard‐duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON‐96 trial by Annoek E C Broers, Ellen Meijer, Bronno van der Holt, Cornelis N de Jong, Erfan Nur, Geerte L van Sluis, Goda Choi, Michel van Gelder, Johan A Maertens, Jürgen Kuball, Dries Deeren, Heleen A Visser‐Wisselaar, Lamberdina A H M Meulendijks, Jan J Cornelissen, the HOVON Stem Cell Transplantation Workin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11632395.txt.

Description

Annoek Broers and a large trial group published transplant results in two thousand twenty-four on shortening immune suppression after stem cell transplant. Donor stem cells can attack the patient's body, so preventive drugs are standard. How long they must run was undefined, and overtreatment carries its own harms.

The HOVON-96 trial randomised three hundred eighty-nine patients to standard or time-restricted suppression. The main goal, mild graft-versus-host disease within six months, occurred at nearly identical rates, about a quarter in both arms. Severe acute and chronic forms also matched. The authors conclude the shorter course did not buy the hoped-for shift toward milder disease. Survival and relapse detail fills the full report.

Catalog record

CREATORAnnoek E C Broers, Ellen Meijer, Bronno van der Holt, Cornelis N de Jong, Erfan Nur, Geerte L van Sluis, Goda Choi, Michel van Gelder, Johan A Maertens, Jürgen Kuball, Dries Deeren, Heleen A Visser‐Wisselaar, Lamberdina A H M Meulendijks, Jan J Cornelissen, the HOVON Stem Cell Transplantation Workin
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11632395

Browse the full library · About the Tower of Babel